CVS (CVS) Sept Comps Up 8.8%; Raises EPS Guidance
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $93.02 -0.67%
Financial Fact:
Income before income tax provision: 2.46B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Income before income tax provision: 2.46B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
CVS Corporation (NYSE: CVS) announced that total revenues for the five-week period ended September 30, 2006 increased 24.3% to $4.4 billion. Total pharmacy revenues represented 70.7% of total company revenues in September. Same store sales (sales from stores open more than one year) for the five weeks ended September 30, 2006 increased 8.8% over the prior year period.
CFO, David Rickard, said, "Given the strong trends in our business, we are raising our diluted earnings per share guidance for the third quarter, from a range of $0.28 - $0.30 to a range of $0.31 - $0.33. Consistent with that change, we are also raising our diluted earnings per share guidance for the full year 2006, from a range of $1.47 - $1.51 to a range of $1.50 - $1.54."
CFO, David Rickard, said, "Given the strong trends in our business, we are raising our diluted earnings per share guidance for the third quarter, from a range of $0.28 - $0.30 to a range of $0.31 - $0.33. Consistent with that change, we are also raising our diluted earnings per share guidance for the full year 2006, from a range of $1.47 - $1.51 to a range of $1.50 - $1.54."
You May Also Be Interested In
- CVS Health (CVS) PT Raised to $114 at Argus
- CVS Health names JPMorgan executive to board, Robbins exits
- Morgan Stanley sees a buying opportunity in this data center stock
Create E-mail Alert Related Categories
Guidance, Hot List, Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
